MEDICAID: Provides relative to the Medicaid Pharmaceutical and Therapeutics Committee
Read by title, under the rules, referred to the Committee on Health and Welfare.
Summary
The bill revises the law governing the Medicaid Pharmaceutical and Therapeutics Committee by adding a new member slot for a physician or pharmacist from each Medicaid managed‑care organization and by deleting an existing provision. It also removes certain restrictions on HIV/AIDS medications. These changes aim to broaden professional input on Medicaid drug decisions and improve access to HIV/AIDS treatments.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 927 changes status, plus AI-powered summaries and stage predictions.
Sign up free